Scott Lewis

Scott Lewis has extensive work experience spanning various roles in the biotech and pharmaceutical industry. Scott is currently the Vice President of Strategy and Business Development at Anjarium Biosciences since October 2022. Prior to this, they worked at Cerevel Therapeutics, LLC as the Corporate Development and Strategy Lead from August 2019 to August 2022. Before Cerevel, Scott held multiple positions at Biogen from 2013 to 2019, including Director of Alzheimer's Disease Diagnostic Pathway, Associate Director of Neurodegeneration Therapeutic Area Franchise Team, Senior Manager of Corporate Strategy, and Senior Manager of New Product Commercialization in Neurology. Scott also gained valuable experience at MedImmune, where they served as the Senior Manager of Global Marketing for Emerging Brands and worked as a Consultant and MBA Summer Associate in Global Strategic Marketing. Scott started their career at Archemix Corporation as a Senior Research Associate, where they played a key role in developing novel assays and contributing to various publications. Scott began their professional journey as a Research Assistant at Michigan State University.

Scott Lewis completed their Bachelor of Science degree in Microbiology at Michigan State University from 1996 to 2000. Scott further pursued their education at the University of Maryland - Robert H. Smith School of Business, where they obtained a Master of Business Administration (MBA) specializing in Marketing & Strategy from 2008 to 2010.